Mark For: CERTIS™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 97611518 |
Mark Literal Elements | CERTIS |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Service Mark |
Current Location | NEW APPLICATION PROCESSING 2022-10-01 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Stephen C. Beuerle |
Attorney Docket Number | 99999901US01 |
2018-07-02 | Date of First Use |
2018-08-27 | Date of Use In Commerce |
2022-09-28 | Application Filed |
2022-10-01 | Location: NEW APPLICATION PROCESSING |
2022-10-01 | Status: Live/Pending |
2022-10-01 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
2022-10-01 | Transaction Date |
Party: | Certis Oncology Solutions, Inc. |
Address | Suite 110 5626 Oberlin Dr. San Diego, CALIFORNIA UNITED STATES 92121 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Application | 2022-09-28 | |
Drawing | 2022-09-28 | |
Specimen | 2022-09-28 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | Medical and technology research in the field of oncology; Providing scientific research, bioinformatics analysis, and related information applicable to disease detection and treatment, precision and personalized medicine, pharmaceutical and other cancer therapeutics development, companion diagnostics, laboratory-developed tests and clinical decision support software in the field of oncology |
GS0421 | Medical and technology research in the field of oncology; Providing scientific research; Developing diagnostic testing models for others for medical, clinical, and scientific purposes for use in disease detection and treatment, precision and personalized medicine, pharmaceutical and other cancer therapeutics development, companion diagnostics, laboratory-developed tests and for developing computer software for clinical decision support in the field of oncology |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.